Legal Framework and Penalties

In India, the consequences of failing to declare biological specimens depend on whether the specimens are human samples, animal or plant materials, microorganisms, or biological resources collected for research or commercial use.

1. Biological Diversity Act, 2002: Sections 3, 4, 6 and 7 regulate specified access to biological resources, transfer of research results, intellectual-property applications, and commercial utilisation. Under amended Section 55, covered violations may attract an administrative penalty of ₹1 lakh to ₹50 lakh, potentially proportionate to greater damage, with an additional penalty of up to ₹1 crore for continuing contraventions. The relevant approval or intimation requirement must actually apply to the person and activity.

IndiaCode

+1

2. Import and export requirements: Human biological samples transported across Indian borders must comply with applicable customs declarations, foreign-trade conditions, and relevant safety requirements. The current import policy provides a route for certain diagnostic and clinical-research samples without separate prior import or export permits, subject to an undertaking and compliance with applicable rules. Other categories may require a no-objection certificate or additional authorisation.

DGFT Content

+1

3. Human research specimens: Collecting, storing, or using human biological materials for research generally requires appropriate informed consent and ethics-committee approval under applicable Indian research-ethics guidance. Failure to comply may lead to institutional, regulatory, or civil consequences depending on the circumstances.

ClinRegs

Important Case Laws

1. M. Kottaiya v. State (Forest Range Officer, Gummidipoondi), Criminal Original Petition No. 20823 of 2021 (Madras High Court, 10 July 2023)

The Court quashed proceedings alleging violations of the Biological Diversity Act involving polychaete worms used as feed in shrimp hatcheries. It held that the particular activity did not constitute regulated commercial utilisation under the applicable statutory definition. The case demonstrates that penalties cannot be imposed merely because a biological material is involved; the statutory requirements must be satisfied.

IndiaCode

2. Divya Pharmacy v. Union of India, 2018 SCC OnLine Utt 1035

The Uttarakhand High Court considered benefit-sharing obligations under the Biological Diversity Act in relation to commercial use of biological resources. The case illustrates the importance of complying with biodiversity access and benefit-sharing requirements when using biological materials commercially. It did not directly concern undeclared human specimens.

Conclusion

Undeclared biological specimens can trigger penalties where declaration, authorisation, consent, or reporting is legally required. However, non-declaration does not automatically create one universal offence or fixed penalty. The applicable law depends on the specimen’s origin, type, purpose, and movement across borders, as well as the person handling it.